BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 22, 2016
View Archived Issues
Alectos receives orphan drug designation for MK-8719
Read More
First-in-human results for nesvacumab in patients with advanced solid tumors
Read More
US Phytotherapy demonstrates dengue virus inhibition in preliminary cell culture studies
Read More
COMP as a novel prognostic biomarker in breast cancer
Read More
FDA grants orphan drug designation to DelMar's VAL-083
Read More
Roche patents beta-secretase 1 inhibitors
Read More
Lead Discovery Siena discloses guanidine derivatives
Read More
Merck & Co. reports TrK-A inhibitors
Read More
NITD-008 and galidesivir improve survival and reduce viremia in AG129 mouse model of ZIKV infection
Read More
BioMarin's BMN-250 begins phase I/II trial, awarded European orphan drug designation for MPS IIIB
Read More
Repatha becomes available in Japan
Read More
Positive interim data from phase II trial of KRN-23 as treatment of tumor-induced osteomalacia
Read More
AbbVie and CytomX collaborate on Probody drug conjugate targeting CD71
Read More
Galapagos reports 20-week phase II results for filgotinib in Crohn's disease
Read More
Sitagliptin is not beneficial in nonalcoholic fatty liver disease study
Read More
TapImmune begins phase II trial for cancer vaccine TPIV-200
Read More
AstraZeneca to transform drug discovery and development through new integrated genomics initiative
Read More
Deutetrabenazine exhibits positive effects on tics in adolescents with Tourette syndrome
Read More
Achaogen awarded contract option by NIAID to support LpxC inhibitor research
Read More
Opthea provides update on phase I trial for OPT-302
Read More
FDA gives orphan drug designation to cannabidiol for TSC
Read More
SFARI launches SPARK autism research study
Read More
Janssen files for Japanese approval of Simponi for the treatment of ulcerative colitis
Read More
FDA grants orphan drug designation to NK-012
Read More